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Abstract: The frequency and severity of bacteremic infections has increased over the last 
decade and bacterial endovascular infections (i.e., sepsis or endocarditis) are associated 
with high morbidity and mortality. Bacteria or secreted bacterial products modulate platelet 
function and, as a result, affect platelet accumulation at sites of vascular infection and 
inflammation. However, whether bacterial products regulate synthetic events in platelets is 
not known. In the present study, we determined if prolonged contact with staphylococcal  
α-toxin signals platelets to synthesize B-cell lymphoma (Bcl-3), a protein that regulates 
clot retraction in murine and human platelets. We show that α-toxin induced αIIbβ3-dependent 
aggregation (EC50 2.98 µg/mL ±  0.64 µg/mL) and, over time, significantly altered platelet 
morphology and stimulated de novo accumulation of Bcl-3 protein in platelets. Adherence 
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to  collagen  or  fibrinogen  also  increased  the  expression  of  Bcl-3  protein  by  platelets.  
α-toxin altered Bcl-3 protein expression patterns in platelets adherent to collagen, but not 
fibrinogen. Pretreatment of platelets with inhibitors of protein synthesis or the mammalian 
Target of Rapamycin (mTOR) decreased Bcl-3 protein expression in α-toxin stimulated 
platelets. In conclusion, Staphylococcus aureus-derived α-toxin, a pore forming exotoxin, 
exerts immediate (i.e., aggregation) and prolonged (i.e., protein synthesis) responses in 
platelets, which may contribute to increased thrombotic events associated with gram-positive 
sepsis or endocarditis.  
Keywords: α-toxin; Bcl-3; protein synthesis 
 
1. Introduction  
Mammalian  platelets  adhere  to  exposed  subendothelial  matrix,  secrete  granule  contents,  form 
multicellular aggregates, and serve as a nidus for plasma coagulation reactions [1]. Although these 
roles are well-defined in vascular injury, platelets also rapidly accumulate at sites of vascular injury 
and  infection,  including  infective  endocarditis  and  mycotic  aneurysms  [2,3].  In  these  types  of 
situations, platelets frequently attach to vascular stents and valves where they serve as binding foci for 
bacteria and facilitate the recruitment of additional platelets and leukocytes to the infected site [2–4].  
It is well known that agonists present in the infectious milieu, such as platelet activating factor 
(PAF) and thrombin, induce platelet aggregation and secretion  [5]. However, bacterial toxins also 
modulate  platelet  reactivity.  Among  these,  staphylococcal-derived  α-toxin  directly  [6,7]  or 
indirectly [8] activates platelets, the latter via generation of PAF by endothelial cells. α-toxin is a 
~34 kDa protein secreted by Staphylococcus aureus (S. aureus) that binds and forms pores in target 
cell membrane [9]. The secretogogue and cytolytic activities of α-toxin target a number of mammalian 
cell  types  including  leukocytes,  endothelial  cells,  erythrocytes  and  platelets  [9].  In  addition, 
staphylococcal  α-toxin  is  an  important  virulence  factor  in  the  pathogenesis  of  infections  such  as 
endocarditis or sepsis [3,6].  
Although  several  studies  have  shown  that  α-toxin  induces  immediate  activation  responses  in 
platelets (i.e., within minutes) [6,7] , there is a growing appreciation that activated platelets continue to 
function  over  hours  [10].  One  prolonged  function  of  platelets  is  de  novo  synthesis  of  proteins, 
including  B-cell  lymphoma  (Bcl-3)  [11–14].  Newly  synthesized  Bcl-3  binds  Fyn  and  regulates 
cytoskeletal events in platelets [14] and Bcl-3 deficient platelets lack the capacity to retract fibrin-rich 
clots [13].  
Because platelets, fibrin, and microcolonies of bacteria often vegetate with one another for extended 
periods of time in infective endocarditis and other infectious syndromes, we asked if bacterial toxins 
induce prolonged activation events in platelets. Specifically, we focused on the activating properties of 
α-toxin because S. aureus binds platelets [15] and is a common cause of infective endocarditis [6,16]. 
Our studies demonstrate that α-toxin induces platelets to aggregate, display morphologic features of 
activation, and synthesize Bcl-3 protein.  Toxins 2011, 3  
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2. Materials and Methods  
2.1. Platelet Isolation  
Research was approved by the University of Utah Institutional Review Board and by the Ethics 
Committee at Martin Luther University and all human participants gave written informed consent to 
participate in the study. Washed platelets were isolated as previously described [17]. The platelets 
were resuspended in Medium 199 (serum free) at a concentration (2 ×  10
8/mL) that falls within the 
normal range of platelets found in 1 mL of whole blood. For studies where the platelets were left in 
suspension,  soluble  fibrinogen  (100  g/mL)  was  added  to  the  culture  to  mimic  the  presence  of 
fibrinogen found in human plasma [13]. The purity and activation state of the platelet preparation was 
analyzed by FACS analysis with CD61, CD62, and CD154. On average, we observed less than two 
leukocytes per 1,000 platelets (data not shown). For the majority of experiments, the platelets were 
processed immediately (i.e., time 0) or activated with  0.05 U/mL of thrombin (Sigma, Steinheim, 
Germany)  or  500  ng/mL  of  α-toxin  (Sigma)  for  designated  times.  This  concentration  of  α-toxin 
approximates 50% of the amount released by 9 ×  10
4 CFUs of a clinical strain of S. aureus that was 
resuspended  in  1  mL  of  M199  medium  (Supplemental  Figure  1).  Using  strains  of  S.  aureus  that 
produce α-toxin, Bayer et al. [6] observed that challenge inocula between 10
4 and 10
6 CFUs adhere to 
sterile cardiac vegetations and induce experimental endocarditis.  
The activation studies were done in platelets that were left in suspension or adhered to immobilized 
fibrinogen or collagen (see below). To gauge protein synthesis, platelets were pre-treated for 30 minutes 
with puromycin (Sigma), rapamycin (Calbiochem, Merck KGaA, Darmstadt, Germany), wortmannin 
(Sigma), or their vehicle (dimethylsulfoxide) (Sigma).  
2.2. Platelet Aggregation  
Washed  platelets  were  resuspended  (2  ×   10
8  platelets/mL)  in  platelet  poor  plasma  (PPP)  and 
aggregation  was  measured  with  an  APACT  (Automated  Platelet  Aggregation  Coagulation  Tracer, 
Achrensburg, Germany) according to the method of Born [18]. Aggregation was induced by increasing 
concentrations of α-toxin. Abciximab, an antibody that blocks IIb3-dependent aggregation, was also 
tested against 5 g/mL of α-toxin. This concentration was chosen based on the EC50 of α-toxin for 
inducing platelet aggregation.  
2.3. Adherence of Platelets to Immobilized Surfaces  
Platelet  adhesion  was  carried  out  in  six-well  plates  or  borosilicate  chamber  slides  that  were 
previously coated overnight (4 ° C) with fibrinogen purified from human plasma (Calbiochem, Merck 
KGaA,  Darmstadt,  Germany),  type  I  collagen  (Sigma),  or  human  serum  albumin  (HSA;  Bayer, 
Leverkusen,  Germany)  as  previously  described  by  our  group  [12,19].  Before  the  start  of  each 
experiment,  the coated  wells  were blocked with HSA (1%)  and washed prior to  adding platelets. 
Washed platelets were allowed to adhere to each surface in the presence of agonists (i.e., α-toxin or 
thrombin) for the indicated times. At the end of each experiment, the platelets were placed directly in 
SDS-PAGE reducing buffer for Western analysis.  Toxins 2011, 3  
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2.4. Immunocytochemistry (ICC)  
Platelets were left quiescent or activated as described above. Suspension cells were directly fixed in 
suspension  using  2%  paraformaldehyde  for  20  minutes  at  room  temperature  and  then  adhered  to 
vectabond
TM
 (Vector Laboratories, Burlingame, CA, U.S.A) coated glass-coverslips using a cytospin 
centrifuge  (Shandon  Cytospin,  Thermo  Fisher  Scientific,  Waltham,  MA)  as  previously 
described [20,21]. Adherent platelets were directly fixed on borosilicate chamber slides [21]. The cells 
were stained with Alexa Fluo® 488 phalloidin (A12379;  Invitrogen, Eugene, OR), a high-affinity 
probe for F-actin, and Alexa Fluor® 555 conjugate of wheat germ agglutinin (WGA; Invitrogen), a 
probe  that  binds  sialic  acids.  The  microscopy  was  performed  using  an  Olympus  IX81,  FV300 
(Olympus,  Melville,  NY,  U.S.A)  confocal-scanning  microscope  equipped  with  a  60× /1.42  NA  oil 
objective  for  viewing  platelets.  An  Olympus  FVS-PSU/IX2-UCB  camera  and  scanning  unit  and 
Olympus  Fluoview  FV  300  image  acquisition  software  version  5.0  were  used
 
for  recording.  The 
images were further analyzed using Adobe Photoshop CS version 8.0 and ImageJ (NIH). 
2.5. Western Blot Analysis  
Platelet proteins were separated by electrophoresis using a 9% SDS-polyacrylamide gel. Proteins 
were  transferred  to  a  polyvinylidene  disulfide  membrane  and  probed  for  Bcl-3  as  previously 
described [11,12,14]. The antibody directed against Bcl-3 was raised against amino acids 301–446 of 
human Bcl-3 (Santa Cruz Technology, Santa Cruz, CA, USA). Each sample was also probed for actin 
to ensure equal loading of proteins.  
2.6. Reverse Transcriptase–PCR (RT-PCR) 
Total RNA was isolated from purified human platelets (1 ×  10
9) using 1 mL TRIzol® reagent as 
previously described [11,14]. One g of the RNA was used as a template for single-strand cDNA 
synthesis,  which  was  generated  with  Moloney  murine  leukemia  virus  reverse  transcriptase 
(GIBCO/BRL) using the conditions supplied by the manufacturer. The primers for Bcl-3 were the 
following: sense, 5’-CGA CGC AGT GGA CAT TAA GA-3’ and anti-sense, 5’-AGA TGG GGA 
AGG AAG GAA GA-3’.  
3. Results  
First,  we  determined  if  α-toxin  induces  aggregation,  an  activity  of  platelets  that  occurs  within 
seconds to minutes. We found that α-toxin induced platelet aggregation within a minute and in a 
concentration-dependent  manner  [Figure  1(A)].  The  EC50  for  α-toxin  induced  aggregation  was  
2.98 ±  0.64 µg/mL. Pretreatment of platelets with a blocking antibody directed against integrin IIb3 
inhibited α-toxin induced platelet aggregation [Figure 1(B)].  Toxins 2011, 3  
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Figure 1. -toxin induces integrin IIb3-dependent aggregation in platelets. Platelets were 
prepared  as  described  in  Materials  and  Methods  and  aggregation  responses  were 
monitored.  (A)  (upper)  Aggregation  was  measured  in  platelets  that  were  treated  with 
increasing  concentrations  of  α-toxin  (0.5–10  g/mL).  (B)  (lower)  Aggregation  was 
measured in platelets that were pretreated with varying concentrations of abciximab, which 
blocks IIb3-dependent aggregation, followed by stimulation with α-toxin (5 μg/mL). The 
fitted curves in both graphs are based on the mean ±  SEM of four independent experiments.  
 
 
Next, we assessed the effects of prolonged incubation of α-toxin on platelet morphology and Bcl-3 
synthesis. Freshly-isolated (Figure 2(A), top panels) or unstimulated platelets that were cultured in 
suspension (Figure 2(A), middle panels) were discoid and their granules, as indexed by WGA, were 
evenly distributed throughout the cell indicative of a non-activated state. In contrast, α-toxin induced 
several distinct morphologic features in platelets after four hours (Figure 2(A), bottom panels): first, 
several  platelets  were  visibly  lysed  and  small,  cellular  fragments  were  readily  observed  in  the 
extracellular  milieu;  second,  intracellular  granules  were  less  obvious;  third,  pseudopodia  extended 
from intact platelets and thin strands, which stained positive for WGA, interconnected platelets with 
one another; and fourth, polymerized actin coalesced to the cell center and was more condensed in  
α-toxin treated samples compared to unactivated controls.  Toxins 2011, 3  
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Figure 2. Prolonged exposure to α-toxin induces distinct morphologic changes in platelets. 
(A) Freshly-isolated platelets were fixed immediately (time = 0) or cultured for 240 minutes 
in  suspension  in  the  presence  of  soluble  fibrinogen,  with  or  without  α-toxin,  prior  to 
fixation. (B-C) Platelets were adhered to immobilized fibrinogen (B) or collagen (C) in the 
presence or absence of α-toxin for 240 minutes. After this time period, the platelets were 
fixed. In (A-C), polymerized actin (F-actin) is represented by green while WGA staining 
(Sialic acid) is shown in red. The yellow represents co-localization of polymerized actin 
with sialic acids. The far right panels are high magnification insets taken from the boxes 
depicted in the “Merge” column. The white arrows point to discrete morphologic features. 
The scale bars equal 10 m. These figures are representative of two independent experiments.  
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As  expected,  platelets  adhered  to  fibrinogen  or  collagen  over  a  four  hour  time  period  
(Figures  2(B,C),  top  panels).  The  adherent  platelets  displayed  features  of  activation,  including 
pseudopodia extensions and their granules moved to the middle of the cell. Co-incubation with α-toxin 
did not significantly alter the adherence of platelets to either extracellular matrix (Figures 2(B,C), 
bottom panels). However, α-toxin stimulated platelets failed to extend pseudopodia and they remained 
round. They also distributed their remaining granules towards the cell membrane and condensed their 
polymerized actin [Figures 2(B,C), bottom panels].  
Figures 1 and 2 demonstrate that α-toxin has immediate and prolonged effects on platelets. To 
explore prolonged responses in more detail, we screened for Bcl-3 synthesis in α-toxin stimulated 
platelets. Previous studies have shown that Bcl-3 is synthesized by thrombin-activated platelets, a 
response that requires engagement of IIb3 integrins on the surface of platelets [11–14]. Consistent 
with published work [11,14], Bcl-3 mRNA was detected in unactivated and α-toxin stimulated human 
platelets [Figure 3(A)]. In contrast, cultured platelets accumulated Bcl-3 protein, a response that was 
accentuated by α-toxin [Figure 3(B)]. Specifically, we observed trace amounts of Bcl-3 protein in 
platelets that were resuspended in M199 with soluble fibrinogen [lane 1; Figure 3(B)], which may be 
due to auto-activation of platelets during the four hour culture period. Thrombin or α-toxin accentuated 
Bcl-3 protein expression in platelets that were resuspended and cultured in the presence of soluble 
fibrinogen [lanes 2 and 3; Figure 3(B)]. The addition of leukocytes to platelet preparations did not 
enhance  the  expression  of  Bcl-3  protein  (data  not  shown).  These  results,  in  combination  with  
Figure 3(A) showing that α-toxin does not induce transcription of Bcl-3 mRNA, demonstrate that 
contaminating leukocytes do not contribute to increased Bcl-3 protein expression in these studies.  
Consistent with previous studies from our group [12], platelets adherent to immobilized fibrinogen 
or collagen accumulated Bcl-3 protein in a time-dependent fashion [Figure 3(C) and Supplemental 
Figure  2(A,B)].  Thrombin  or  α-toxin  did  not  appreciably  increase  Bcl-3  protein  expression  in 
fibrinogen-adherent platelets [Figure 3(C) and Supplemental Figure 2(A)]. In contrast, Bcl-3 protein 
expression was markedly increased in collagen-adherent platelets that were co-incubated with α-toxin 
for four hours [Supplemental Figure 2(B)]. This increase, however, waned considerably after a 12 hour 
period [Supplemental Figure 2(B)]. 
We previously demonstrated that Bcl-3 synthesis is controlled by mTOR in thrombin-activated 
platelets [13,14]. To determine if α-toxin activates similar signaling pathways, we pretreated platelets 
with rapamycin or wortmannin. Rapamycin negates mTOR activity while wortmannin neutralizes the 
activity of phosphoinositide 3-kinase (PI3K), which is upstream of mTOR [14]. We found that both 
inhibitors  attenuated  Bcl-3  protein  expression  in  α-toxin  stimulated  platelets  [Figure  4(A,B)]. 
Puromycin, a global inhibitor of mRNA translation, also significantly reduced Bcl-3 protein expression 
in α-toxin-stimulated platelets [Figure 4(C)]. Toxins 2011, 3  
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Figure 3. α-toxin accentuates Bcl-3 protein accumulation in platelets. (A) Freshly-isolated 
platelets were cultured in suspension in the presence of soluble fibrinogen alone (lane 1) or 
soluble fibrinogen and α-toxin (lane 2). After 240 minutes, Bcl-3 mRNA was assessed in 
both samples (right panel). The left panel displays 18S rRNA, as a loading control for  
Bcl-3. RNA gels are representative of three independent experiments. (B) Freshly-isolated 
platelets were cultured in suspension in the presence (lane 1) of soluble fibrinogen for  
240 minutes and Bcl-3 (top panel) or actin (bottom panel) protein expression was assessed. 
Samples  with  soluble  fibrinogen  were  also  treated  with  thrombin  (lane  2)  or  α-toxin  
(lane 3). (C) Freshly-isolated platelets were cultured in suspension (lane 1) or adhered to 
immobilized fibrinogen  for 240 minutes and Bcl-3 (top panel) or  actin (bottom panel) 
protein expression was assessed. Platelets that adhered to immobilized fibrinogen were 
treated with vehicle (lane 2), thrombin (lane 3), or α-toxin (lane 4). The protein gels (B-C) 
are representative of five independent experiments. The dividing lines between lanes 2  
and 3 in (B) and lanes 3 and 4 in (C) represent elimination of a lane, which was run on the 
same gel but not relevant to the current study.  
 Toxins 2011, 3  
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Figure  4.  Accumulation  of  Bcl-3  protein  in  α-toxin  stimulated  platelets  is  reduced  by 
protein synthesis inhibitors. Freshly-isolated platelets were cultured in suspension in the 
presence of rapamycin (A), wortmannin (B), or puromycin (C) for 30 minutes. After this 
incubation period, soluble fibrinogen was added to the culture and then the platelets were 
treated with  vehicle, thrombin, or α-toxin for 240 minutes. Bcl-3 (top panels) or actin 
(bottom panels) protein expression was subsequently assessed by Western blot analysis. 
The gels in each figure are representative of five independent experiments. The bars below 
each gel display the average densitometry data for each experimental condition (mean ±  SEM, 
n  =  5).  Note,  all  samples  were  run  on  the  same  gel  but,  in  some  cases  (B  and  C), 
comparative samples were separated by extra lanes and therefore cropped individually. 
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4. Discussion  
Gram-positive S. aureus is the most frequent causative organism of infective endocarditis [16], a 
disease characterized by colonies of bacteria and platelets that reside on cardiac valves [3]. Strains of 
S. aureus  that  produce  α-toxin  are  present  in  cardiac  vegetations  and  induce  experimental 
endocarditis [6]. Previous studies have  also shown that specific components of S. aureus, such as 
clumping  factor  A  and  fibronectin  binding  protein  A,  regulate  immediate  responses  of  platelets 
including aggregation [22]. α-toxin rapidly activates platelets by integrating into platelet membranes 
and  promoting  blood  coagulation  [7,9],  and  intravenous  administration  of  α-toxin  in  cynomolgus 
monkeys elicits a selective drop in platelets counts [23]. Here, we show that α-toxin also induces 
prolonged responses in platelets, including distinct morphologic signs of activation and synthesis of 
Bcl-3 protein. These types of activation events may exist in infective endocarditis where platelet and 
S. aureus vegetate with one another and α-toxin is continually secreted into the local milieu. 
α-toxin  forms  pores  in  cellular  membranes  that  facilitate  an  influx  of  extracellular  Ca
2+  [24]. 
Calcium fluxes contribute to α-toxin’s cytolytic effect on target cells and, over time, may contribute to 
the morphologic features observed in the present study. When suspension platelets were exposed to  
α-toxin for four hours, they were visibly activated. α-toxin stimulated platelets extended pseudopodia 
and cellular fragments were observed throughout the extracellular milieu. Another striking feature is 
the development of “string-like” interconnections between α-toxin stimulated platelets. It is possible 
that these strings are fibrin strands, which evolve as platelets retract clots. Previous studies from our 
group demonstrate that washed platelet preparations develop and retract fibrin strands when they are 
cultured and activated in the presence of soluble fibrinogen [13]. Another possibility is that these 
string-like structures are thin extensions of cell membrane, especially since they stain for sialic acids. 
They do not, however, stain for actin. Whether these strands are made of fibrin, fibrin that is laced by 
sialic acids, or are extensions of sialic-rich cell membranes requires further investigation. Nevertheless, 
these  results  suggest  that  α-toxin  induces  platelets  to  produce  extracellular  tethers  that  promote 
platelet-platelet interactions. This response, in combination with the generation of microparticle debris, 
may also contribute to the pro-coagulant activities of α-toxin on platelets [9].  
Albeit different than responses in suspension cultures, α-toxin also induced morphologic changes in 
platelets that adhered to extracellular matrices. The most prominent feature is that adherent platelets 
distribute their granules to the cell periphery. This suggests that α-toxin stimulated platelets secrete 
their granule contents as they adhere to immobilized collagen or fibrinogen. Adherent platelets also 
coalesced polymerized actin, but they did not extend pseudopodia in response to α-toxin and, in fact, 
remained  discoid  and  readily  adhered  to  both  extracellular  matrices.  These  results  indicate  that 
platelets retain their capacity to adhere and mobilize intracellular granules in the presence of α-toxin, 
but suggest that α-toxin induces distinct morphologic changes in circulating versus adherent platelets. 
It is also possible that the adherent platelets initially extended, and then retracted, pseudopodia at 
earlier time points that were not captured by the current experimental parameters. 
In addition to its effects on platelet morphology, α-toxin induced Bcl-3 protein synthesis by platelets. 
Bcl-3 is an oncogene that was unexpectedly identified in activated, but not resting, platelets [14]. We 
previously demonstrated that platelets express and translate mRNA for Bcl-3 in response to collagen or 
thrombin stimulation [12,14]. α-toxin adds to the repertoire of agonists that induce Bcl-3 synthesis by Toxins 2011, 3  
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platelets  and  suggests  that  S.  aureus  and  other  bacterial  strains  may  have  similar  effects.  Indeed, 
Shashkin and colleagues [25] recently demonstrated that E. Coli-derived lipopolysaccharide induces 
the synthesis of interleukin-1 protein by platelets. Similar to thrombin stimulated platelets [13,14], 
the  mTOR  translational  control  pathway  regulates  α-toxin  induced  Bcl-3  protein  synthesis.  
mTOR-dependent synthesis of Bcl-3 controls platelet-dependent clot retraction [13]. It is also likely 
that  α-toxin  stimulated  platelets  synthesize  Bcl-3  to  facilitate  platelet-dependent  clot  retraction, 
especially since platelets condense and coalesce polymerized actin in response to α-toxin.  
Platelets synthesize Bcl-3 via integrin IIb3. In this regard, previous studies from our group showed 
that  platelets  from  patients  with  Glanzmann  Thrombasthenia,  which  lack  integrin  IIb3,  do  not 
synthesize Bcl-3 [12]. This, in combination with inhibitory antibody based studies, demonstrated that 
platelets  rely  on  integrin  IIb3  for  Bcl-3  synthesis  [12].  In  the  current  study,  α-toxin  induces  
IIb3-dependent  aggregation suggesting that platelets  use similar outside-in  signaling pathways  to 
synthesize Bcl-3 when they are exposed to α-toxin. In support of this, suspension cultured platelets 
synthesized Bcl-3 in the presence of soluble fibrinogen, which enhances IIb3-dependent aggregation. 
As previously shown by our group [12] and confirmed here, we also found that platelets synthesized 
Bcl-3 after they adhered to immobilized fibrinogen. Adherence to immobilized fibrinogen directly 
activates  integrin  IIb3  [26].  α-toxin,  however,  did  not  accentuate  Bcl-3  synthesis  by  fibrinogen-
adherent platelets. α-toxin did increase Bcl-3 synthesis by platelets that adhered to collagen for four 
hours, but not longer time periods. The reasons for these differential synthetic responses between 
fibrinogen  and  collagen  and  the  temporal  variances  in  collagen-adherent  platelets  are  not  clear. 
Nonetheless, they demonstrate that multiple types of signaling events are capable of inducing Bcl-3 
synthesis by platelets. 
In summary, interactions between platelets and S. aureus are common in infective endocarditis and 
the results from the current study indicate that S. aureus-derived exotoxins induce immediate and 
prolonged  activation  responses  in  target  platelets.  α-toxin’s  effects  on  platelet  function  may  have 
adverse  consequences  during  the  development,  evolution  and  resolution  of  endocarditis  and  other 
infectious situations. 
Acknowledgements 
This work is supported in part by grants from the Deutsche Forschungsgemeinschaft (Bu 819/5-2), 
the National Institutes of Health (HL66277, HL91754, and HL90870 to A.S.W.), and the American 
Heart Association (0625098Y and 09BGIA2250381). We would like to thank Doris Schulz for the 
technical support during the course of these experiments and Diana Lim for preparing the figures. 
References 
1.  Davi,  G.;  Patrono,  C.  Platelet  activation  and  atherothrombosis.  N.  Engl.  J.  Med.  2007,  357,  
2482–2494. 
2.  Durack,  D.T.  Experimental  bacterial  endocarditis.  IV.  Structure  and  evolution  of  very  early 
lesions. J. Pathol. 1975, 115, 81–89. 
3.  Fitzgerald, J.R.; Foster, T.J.; Cox, D. The interaction of bacterial pathogens with platelets. Nat. 
Rev. Microbiol. 2006, 4, 445–457. Toxins 2011, 3  
 
 
131 
4.  Herzberg,  M.C.  Platelet-streptococcal  interactions  in  endocarditis.  Crit.  Rev.  Oral  Biol.  Med. 
1996, 7, 222–236. 
5.  Bozza, F.A.; Shah, A.M.; Weyrich, A.S.; Zimmerman, G.A. Amicus or adversary: Platelets in 
lung biology, acute injury, and inflammation. Am. J. Respir. Cell Mol. Biol. 2009, 40, 123–134. 
6.  Bayer,  A.S.;  Ramos,  M.D.;  Menzies,  B.E.;  Yeaman,  M.R.;  Shen,  A.J.;  Cheung,  A.L. 
Hyperproduction  of  alpha-toxin  by  Staphylococcus  aureus  results  in  paradoxically  reduced 
virulence in  experimental endocarditis:  A host defense role for platelet microbicidal proteins. 
Infect. Immun. 1997, 65, 4652–4660. 
7.  Bhakdi, S.; Muhly, M.; Mannhardt, U.; Hugo, F.; Klapettek, K.; Mueller-Eckhardt, C.; Roka, L. 
Staphylococcal alpha toxin promotes blood coagulation via attack on human platelets. J. Exp. 
Med. 1988, 168, 527–542. 
8.  Suttorp,  N.;  Buerke,  M.;  Tannert-Otto,  S.  Stimulation  of  PAF-synthesis  in  pulmonary  artery 
endothelial cells by Staphylococcus aureus alpha-toxin. Thromb. Res. 1992, 67, 243–252. 
9.  Bhakdi, S.; Tranum-Jensen, J. Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 1991, 55, 
733–751. 
10.  Weyrich, A.S.; Lindemann, S.; Zimmerman, G.A. The evolving role of platelets in inflammation. 
J. Thromb. Haemost. 2003, 1, 1897–1905. 
11.  Lindemann, S.; Tolley, N.D.; Eyre, J.R.; Kraiss, L.W.; Mahoney, T.M.; Weyrich, A.S. Integrins 
regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets. A checkpoint 
for translational control. J. Biol. Chem. 2001, 276, 33947–33951. 
12.  Pabla, R.; Weyrich, A.S.; Dixon, D.A.; Bray, P.F.; McIntyre, T.M.; Prescott, S.M.; Zimmerman, 
G.A. Integrin-dependent control of translation: engagement of integrin alphaIIbbeta3 regulates 
synthesis of proteins in activated human platelets. J. Cell. Biol. 1999, 144, 175–184. 
13.  Weyrich, A.S.; Denis, M.M.; Schwertz, H.; Tolley, N.D.; Foulks, J.; Spencer, E.; Kraiss, L.W.; 
Albertine, K.H.; McIntyre, T.M.; Zimmerman, G.A. mTOR-dependent synthesis of Bcl-3 controls 
the retraction of fibrin clots by activated human platelets. Blood 2007, 109, 1975–1983. 
14.  Weyrich,  A.S.;  Dixon,  D.A.;  Pabla,  R.;  Elstad,  M.R.;  McIntyre,  T.M.;  Prescott,  S.M.; 
Zimmerman, G.A. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human 
platelets. Proc. Natl. Acad. Sci. USA 1998, 95, 5556–5561. 
15.  Herrmann, M.; Lai, Q.J.; Albrecht, R.M.; Mosher, D.F.; Proctor, R.A. Adhesion of Staphylococcus 
aureus to surface-bound platelets: Role of fibrinogen/fibrin and platelet integrins. J. Infect. Dis. 
1993, 167, 312–322. 
16.  Fowler, V.G., Jr.; Miro, J.M.; Hoen, B.; Cabell, C.H.; Abrutyn, E.; Rubinstein, E.; Corey, G.R.; 
Spelman, D.; Bradley, S.F.; Barsic, B.; Pappas, P.A.; Anstrom, K.J.; Wray, D.; Fortes, C.Q.; 
Anguera, I.; Athan, E.; Jones, P.; van der Meer, J.T.; Elliott, T.S.; Levine, D.P.; Bayer, A.S. 
Staphylococcus  aureus  endocarditis:  A  consequence  of  medical  progress.  JAMA  2005,  293,  
3012–3021. 
17.  Weyrich,  A.S.;  Elstad,  M.R.;  McEver,  R.P.;  McIntyre,  T.M.;  Moore,  K.L.;  Morrissey,  J.H.; 
Prescott,  S.M.;  Zimmerman,  G.A.  Activated  platelets  signal  chemokine  synthesis  by  human 
monocytes. J. Clin. Invest. 1996, 97, 1525–1534. 
18.  Born, G.V. Aggregation of blood  platelets  by adenosine diphosphate and its  reversal.  Nature 
1962, 194, 927–929. Toxins 2011, 3  
 
 
132 
19.  Galt, S.W.; Lindemann, S.; Medd, D.; Allen, L.L.; Kraiss, L.W.; Harris, E.S.; Prescott, S.M.; 
McIntyre,  T.M.;  Weyrich,  A.S.;  Zimmerman,  G.A.  Differential  regulation  of  matrix 
metalloproteinase-9  by  monocytes  adherent  to  collagen  and  platelets.  Circ.  Res.  2001,  89,  
509–516. 
20.  Schwertz, H.; Koster, S.; Kahr, W.H.; Michetti, N.; Kraemer, B.F.; Weitz, D.A.; Blaylock, R.C.; 
Kraiss,  L.W.;  Greinacher,  A.;  Zimmerman,  G.A.;  Weyrich,  A.S.  Anucleate  platelets  generate 
progeny. Blood 2010, 115, 3801–3809. 
21.  Schwertz,  H.;  Tolley,  N.D.;  Foulks,  J.M.;  Denis,  M.M.;  Risenmay,  B.W.;  Buerke,  M.;  
Tilley,  R.E.;  Rondina,  M.T.;  Harris,  E.M.;  Kraiss,  L.W.;  Mackman,  N.;  Zimmerman,  G.A.; 
Weyrich, A.S. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity 
of human platelets. J. Exp. Med. 2006, 203, 2433–2440. 
22.  O’Brien,  L.;  Kerrigan,  S.W.;  Kaw,  G.;  Hogan,  M.;  Penades,  J.;  Litt,  D.;  Fitzgerald,  D.J.;  
Foster, T.J.; Cox, D. Multiple mechanisms for the activation of human platelet aggregation by 
Staphylococcus aureus: Roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat 
protein SdrE and protein A. Mol. Microbiol. 2002, 44, 1033–1044. 
23.  Bhakdi,  S.;  Mannhardt,  U.;  Muhly,  M.;  Hugo,  F.;  Ronneberger,  H.;  Hungerer,  K.D.  Human 
hyperimmune globulin protects against the cytotoxic action of staphylococcal alpha-toxin in vitro 
and in vivo. Infect. Immun. 1989, 57, 3214–3220. 
24.  Suttorp,  N.;  Habben,  E.  Effect  of  staphylococcal  alpha-toxin  on  intracellular  Ca2+  in 
polymorphonuclear leukocytes. Infect. Immun. 1988, 56, 2228–2234. 
25.  Shashkin, P.N.; Brown, G.T.; Ghosh, A.; Marathe, G.K.; McIntyre, T.M. Lipopolysaccharide is a 
direct agonist for platelet RNA splicing. J. Immunol. 2008, 181, 3495–3502. 
26.  Haimovich, B.; Lipfert, L.; Brugge, J.S.; Shattil, S.J. Tyrosine phosphorylation and cytoskeletal 
reorganization in platelets are triggered by interaction of integrin receptors with their immobilized 
ligands. J. Biol. Chem. 1993, 268, 15868–15877. 
Supplemental Materials 
Figure  1.  Methicillin  Resistant  Staphyloccal  Aureus  (MRSA)  secretes  α-toxin.  MRSA  
(9 ×  10
4 CFU), which was isolated from a patient diagnosed with sepsis, was placed in 
M199 (1 mL) media for eight hours. A portion of the releasate (50 L) was subsequently 
placed  in  an  equal  amount  of  SDS  loading  buffer.  The  releasate  was  separated  by 
electrophoresis and probed with an antibody directed against α-toxin. Varying amounts of 
recombinant α-toxin (156 ng, 312 ng, 625 ng, and 1.25 g) were run in parallel. This 
experiment is representative of two independent experiments. 
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Figure 2. α-Toxin alters Bcl-3 protein accumulation in platelets adherent to collagen, but 
not  fibrinogen.  (A)  Freshly-isolated  platelets  were  cultured  in  suspension  (lane  1)  or 
adhered to immobilized fibrinogen for 12 hours in presence of vehicle (lane 2), thrombin 
(lane 3), or α-toxin (lane 4). The top and bottom panels display Bcl-3 and actin expression, 
respectively. The dividing line between lanes 3 and 4 represent elimination of a lane, which 
was run on the same gel but not relevant to the current study. The gel is representative of 
five independent experiments. (B) Freshly-isolated platelets were cultured in suspension 
(lane 1) or adhered to immobilized collagen for four hours in presence of vehicle (lane 2) 
or α-toxin (lane 4) or 12 hours in the presence of vehicle (lane 3) or α-toxin (lane 5). The 
top and bottom panels display Bcl-3 and actin expression, respectively. The dividing line 
between lanes 3 and 4 represent elimination of a lane, which was run on the same gel but 
not relevant to the current study. The gel is representative of four independent experiments.  
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